

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | cytoplasmic mRNA processing body assembly (GO:0033962) | 9.80829530 |
| 2 | regulation of establishment of cell polarity (GO:2000114) | 9.16810685 |
| 3 | sex differentiation (GO:0007548) | 8.13143678 |
| 4 | sterol catabolic process (GO:0016127) | 7.41252780 |
| 5 | cholesterol catabolic process (GO:0006707) | 7.41252780 |
| 6 | regulation of establishment or maintenance of cell polarity (GO:0032878) | 7.35977817 |
| 7 | stress granule assembly (GO:0034063) | 7.19319574 |
| 8 | positive regulation of vasculogenesis (GO:2001214) | 7.02259087 |
| 9 | type I interferon signaling pathway (GO:0060337) | 6.70801888 |
| 10 | cellular response to type I interferon (GO:0071357) | 6.70801888 |
| 11 | alternative mRNA splicing, via spliceosome (GO:0000380) | 6.63412449 |
| 12 | response to type I interferon (GO:0034340) | 6.63332499 |
| 13 | kynurenine metabolic process (GO:0070189) | 6.45827762 |
| 14 | cerebellar Purkinje cell differentiation (GO:0021702) | 6.18538603 |
| 15 | negative regulation of receptor-mediated endocytosis (GO:0048261) | 6.17288274 |
| 16 | indole-containing compound catabolic process (GO:0042436) | 5.89618139 |
| 17 | indolalkylamine catabolic process (GO:0046218) | 5.89618139 |
| 18 | tryptophan catabolic process (GO:0006569) | 5.89618139 |
| 19 | ADP metabolic process (GO:0046031) | 5.85710885 |
| 20 | regulation of metalloenzyme activity (GO:0048552) | 5.82417447 |
| 21 | nucleoside diphosphate catabolic process (GO:0009134) | 5.54433728 |
| 22 | regulation of vasculogenesis (GO:2001212) | 5.33759339 |
| 23 | negative regulation of viral genome replication (GO:0045071) | 5.33161238 |
| 24 | negative regulation of endothelial cell apoptotic process (GO:2000352) | 5.14406743 |
| 25 | tryptophan metabolic process (GO:0006568) | 5.07453607 |
| 26 | positive regulation of heat generation (GO:0031652) | 5.01514374 |
| 27 | cellular response to exogenous dsRNA (GO:0071360) | 4.85408405 |
| 28 | bile acid biosynthetic process (GO:0006699) | 4.80147790 |
| 29 | response to interferon-beta (GO:0035456) | 4.77789238 |
| 30 | centrosome duplication (GO:0051298) | 4.71759781 |
| 31 | lipid particle organization (GO:0034389) | 4.28113861 |
| 32 | regulation of triglyceride catabolic process (GO:0010896) | 4.18230096 |
| 33 | * regulation of MHC class I biosynthetic process (GO:0045343) | 4.03519453 |
| 34 | iron-sulfur cluster assembly (GO:0016226) | 4.00444346 |
| 35 | metallo-sulfur cluster assembly (GO:0031163) | 4.00444346 |
| 36 | positive regulation of tolerance induction (GO:0002645) | 3.97016321 |
| 37 | regulation of T cell tolerance induction (GO:0002664) | 3.96436749 |
| 38 | regulation of regulatory T cell differentiation (GO:0045589) | 3.90497623 |
| 39 | regulation of heat generation (GO:0031650) | 3.77519059 |
| 40 | negative regulation of endothelial cell proliferation (GO:0001937) | 3.77405569 |
| 41 | amine catabolic process (GO:0009310) | 3.72158916 |
| 42 | cellular biogenic amine catabolic process (GO:0042402) | 3.72158916 |
| 43 | regulation of superoxide metabolic process (GO:0090322) | 3.68749009 |
| 44 | regulation of G0 to G1 transition (GO:0070316) | 3.67875371 |
| 45 | steroid catabolic process (GO:0006706) | 3.66469975 |
| 46 | cellular response to interferon-alpha (GO:0035457) | 3.66389931 |
| 47 | positive regulation of fatty acid beta-oxidation (GO:0032000) | 3.65857769 |
| 48 | regulation of membrane protein ectodomain proteolysis (GO:0051043) | 3.63202452 |
| 49 | purine ribonucleoside diphosphate metabolic process (GO:0009179) | 3.62565209 |
| 50 | purine nucleoside diphosphate metabolic process (GO:0009135) | 3.62565209 |
| 51 | positive regulation of defense response to virus by host (GO:0002230) | 3.60981910 |
| 52 | NAD biosynthetic process (GO:0009435) | 3.54262703 |
| 53 | protein autoprocessing (GO:0016540) | 3.54129958 |
| 54 | indolalkylamine metabolic process (GO:0006586) | 3.49257268 |
| 55 | regulation of viral genome replication (GO:0045069) | 3.42817278 |
| 56 | positive regulation of triglyceride biosynthetic process (GO:0010867) | 3.40429681 |
| 57 | aromatic amino acid family catabolic process (GO:0009074) | 3.40035364 |
| 58 | regulation of action potential (GO:0098900) | 3.35311873 |
| 59 | negative regulation of mast cell activation (GO:0033004) | 3.34009805 |
| 60 | phospholipid translocation (GO:0045332) | 3.31970943 |
| 61 | lipid translocation (GO:0034204) | 3.31970943 |
| 62 | regulation of tolerance induction (GO:0002643) | 3.31475235 |
| 63 | positive regulation of peptidyl-serine phosphorylation of STAT protein (GO:0033141) | 3.30491911 |
| 64 | regulation of peptidyl-serine phosphorylation of STAT protein (GO:0033139) | 3.30491911 |
| 65 | negative regulation of viral process (GO:0048525) | 3.30345446 |
| 66 | histone H3-K4 trimethylation (GO:0080182) | 3.29718113 |
| 67 | * defense response to virus (GO:0051607) | 3.27261675 |
| 68 | synaptic transmission, cholinergic (GO:0007271) | 3.24676715 |
| 69 | antigen processing and presentation of exogenous peptide antigen via MHC class I, TAP-independent (G | 3.21860539 |
| 70 | phosphatidylglycerol biosynthetic process (GO:0006655) | 3.19746696 |
| 71 | negative regulation of endothelial cell migration (GO:0010596) | 3.19672900 |
| 72 | regulation of sequestering of triglyceride (GO:0010889) | 3.17261096 |
| 73 | regulation of endothelial cell apoptotic process (GO:2000351) | 3.16088014 |
| 74 | regulation of ER to Golgi vesicle-mediated transport (GO:0060628) | 3.14055575 |
| 75 | regulation of mesenchymal to epithelial transition involved in metanephros morphogenesis (GO:0003339 | 3.13640990 |
| 76 | positive regulation of natural killer cell activation (GO:0032816) | 3.02435855 |
| 77 | interferon-gamma-mediated signaling pathway (GO:0060333) | 3.00456200 |
| 78 | estrogen biosynthetic process (GO:0006703) | 2.97183420 |
| 79 | response to X-ray (GO:0010165) | 2.96451637 |
| 80 | response to cold (GO:0009409) | 2.91975556 |
| 81 | positive regulation of lipid storage (GO:0010884) | 2.91585051 |
| 82 | regulation of interferon-alpha production (GO:0032647) | 2.89817519 |
| 83 | cell differentiation in hindbrain (GO:0021533) | 2.88447835 |
| 84 | somite rostral/caudal axis specification (GO:0032525) | 2.87277331 |
| 85 | pyridine nucleotide biosynthetic process (GO:0019363) | 2.85763565 |
| 86 | nicotinamide nucleotide biosynthetic process (GO:0019359) | 2.85763565 |
| 87 | regulation of phospholipid biosynthetic process (GO:0071071) | 2.84898741 |
| 88 | regulation of defense response to virus by host (GO:0050691) | 2.84698952 |
| 89 | regulation of actin nucleation (GO:0051125) | 2.84634411 |
| 90 | natural killer cell activation involved in immune response (GO:0002323) | 2.84452376 |
| 91 | response to interferon-alpha (GO:0035455) | 2.81719508 |
| 92 | positive regulation of natural killer cell differentiation (GO:0032825) | 2.81032989 |
| 93 | acrosome assembly (GO:0001675) | 2.79245254 |
| 94 | negative regulation of macroautophagy (GO:0016242) | 2.73113675 |
| 95 | regulation of response to reactive oxygen species (GO:1901031) | 2.72387303 |
| 96 | disruption of cells of other organism (GO:0044364) | 2.72246548 |
| 97 | killing of cells of other organism (GO:0031640) | 2.72246548 |
| 98 | bile acid metabolic process (GO:0008206) | 2.71750127 |
| 99 | positive regulation of protein homooligomerization (GO:0032464) | 2.70315331 |
| 100 | negative regulation of multicellular organism growth (GO:0040015) | 10.8930334 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | HOXA2_22223247_ChIP-Seq_E11.5_EMBRYO_Mouse | 6.32377421 |
| 2 | IRF8_21731497_ChIP-ChIP_J774_Mouse | 4.96057708 |
| 3 | IRF1_21803131_ChIP-Seq_MONOCYTES_Human | 4.91929339 |
| 4 | IRF8_22096565_ChIP-ChIP_GC-B_Human | 4.89736292 |
| 5 | BCL11B_21912641_ChIP-Seq_STHDH_STRIUM_Mouse | 3.55509424 |
| 6 | VDR_22108803_ChIP-Seq_LS180_Human | 3.53454812 |
| 7 | SALL1_21062744_ChIP-ChIP_HESCs_Human | 2.96294024 |
| 8 | IRF8_22096565_ChIP-ChIP_GC-B_Mouse | 2.60446384 |
| 9 | SOX9_22984422_ChIP-ChIP_TESTIS_Rat | 2.52547922 |
| 10 | EWS-FLI1_20517297_ChIP-Seq_SK-N-MC_Human | 2.50721237 |
| 11 | TAF15_26573619_Chip-Seq_HEK293_Human | 2.45002566 |
| 12 | TCF21_23034159_ChIP-ChIP_E13_GONADS_Rat | 2.43034590 |
| 13 | TAL1_26923725_Chip-Seq_MACROPHAGESS_Mouse | 2.08123353 |
| 14 | BCAT_22108803_ChIP-Seq_LS180_Human | 2.02323256 |
| 15 | ER_23166858_ChIP-Seq_MCF-7_Human | 1.96735380 |
| 16 | IRF8_27001747_Chip-Seq_BMDM_Mouse | 1.94890461 |
| 17 | CTBP2_25329375_ChIP-Seq_LNCAP_Human | 1.94325658 |
| 18 | VDR_20736230_ChIP-Seq_LYMPHOBLASTOID_Human | 1.71517300 |
| 19 | MYB_26560356_Chip-Seq_TH2_Human | 1.66160685 |
| 20 | OCT1_27270436_Chip-Seq_PROSTATE_Human | 1.58382977 |
| 21 | FOXA1_27197147_Chip-Seq_ENDOMETRIOID-ADENOCARCINOMA_Human | 1.57743681 |
| 22 | TAL1_22897851_ChIP-Seq_JUKARTE6-1_Human | 1.57107768 |
| 23 | TCF12/HEB_22897851_ChIP-Seq_JUKARTE6-1_Human | 1.46178549 |
| 24 | DROSHA_22980978_ChIP-Seq_HELA_Human | 1.44552771 |
| 25 | STAT5_23275557_ChIP-Seq_MAMMARY-EPITHELIUM_Mouse | 1.43510756 |
| 26 | PPARG_20176806_ChIP-Seq_THIOMACROPHAGE_Mouse | 1.38527100 |
| 27 | TP63_17297297_ChIP-ChIP_HaCaT_Human | 1.36608006 |
| 28 | NR1I2_20693526_ChIP-Seq_LIVER_Mouse | 1.32508711 |
| 29 | RELA_24523406_ChIP-Seq_FIBROSARCOMA_Human | 1.30875147 |
| 30 | CDX2_22108803_ChIP-Seq_LS180_Human | 1.30365437 |
| 31 | ZFP57_27257070_Chip-Seq_ESCs_Mouse | 1.29945711 |
| 32 | CDX2_20551321_ChIP-Seq_CACO-2_Human | 1.28901783 |
| 33 | TP53_18474530_ChIP-ChIP_U2OS_Human | 1.28441180 |
| 34 | JUN_26020271_ChIP-Seq_SMOOTH_MUSCLE_Human | 1.28157813 |
| 35 | NOTCH1_21737748_ChIP-Seq_TLL_Human | 1.27396545 |
| 36 | JUND_26020271_ChIP-Seq_SMOOTH_MUSCLE_Human | 1.24457466 |
| 37 | CEBPB_23403033_ChIP-Seq_LIVER_Mouse | 1.23167578 |
| 38 | PBX_27287812_Chip-Seq_EMBYONIC-LIMB_Mouse | 1.18380306 |
| 39 | SMAD4_21741376_ChIP-Seq_EPCs_Human | 1.17377107 |
| 40 | CJUN_26792858_Chip-Seq_BT549_Human | 1.17184556 |
| 41 | THRA_23701648_ChIP-Seq_CEREBELLUM_Mouse | 1.14380810 |
| 42 | LMO2_26923725_Chip-Seq_MACROPHAGESS_Mouse | 1.11858749 |
| 43 | EGR1_23403033_ChIP-Seq_LIVER_Mouse | 1.09849043 |
| 44 | UBF1/2_26484160_Chip-Seq_FIBROBLAST_Human | 1.09536488 |
| 45 | GATA4_25053715_ChIP-Seq_YYC3_Human | 1.07691594 |
| 46 | RXRA_24833708_ChIP-Seq_LIVER_Mouse | 1.06369161 |
| 47 | FOXA1_27270436_Chip-Seq_PROSTATE_Human | 1.06283326 |
| 48 | FOXA1_25329375_ChIP-Seq_VCAP_Human | 1.06283326 |
| 49 | ESET_19884257_ChIP-Seq_ESCs_Mouse | 1.06034317 |
| 50 | RCOR2_21632747_ChIP-Seq_MESCs_Mouse | 1.06014915 |
| 51 | LXR_22158963_ChIP-Seq_LIVER_Mouse | 1.04262843 |
| 52 | GATA3_21867929_ChIP-Seq_TH1_Mouse | 1.04142406 |
| 53 | ELF1_20517297_ChIP-Seq_JURKAT_Human | 1.03894660 |
| 54 | GATA3_22897851_ChIP-Seq_JUKARTE6-1_Human | 1.03311761 |
| 55 | TAF2_19829295_ChIP-Seq_ESCs_Human | 1.03185699 |
| 56 | RUNX1_22897851_ChIP-Seq_JUKARTE6-1_Human | 1.02871280 |
| 57 | BACH1_22875853_ChIP-PCR_HELA_AND_SCP4_Human | 1.02773809 |
| 58 | NR3C1_21868756_ChIP-Seq_MCF10A_Human | 1.02554044 |
| 59 | CEBPA_23403033_ChIP-Seq_LIVER_Mouse | 1.02500228 |
| 60 | IGF1R_20145208_ChIP-Seq_DFB_Human | 1.00854211 |
| 61 | KDM2B_26808549_Chip-Seq_REH_Human | 0.99853401 |
| 62 | KLF1_20508144_ChIP-Seq_FETAL-LIVER-ERYTHROID_Mouse | 0.99391177 |
| 63 | RUNX1_20887958_ChIP-Seq_HPC-7_Mouse | 0.98818047 |
| 64 | ARNT_22903824_ChIP-Seq_MCF-7_Human | 0.96142243 |
| 65 | ERA_21632823_ChIP-Seq_H3396_Human | 0.95405583 |
| 66 | FOXA1_21572438_ChIP-Seq_LNCaP_Human | 0.93995410 |
| 67 | OCT4_20526341_ChIP-Seq_ESCs_Human | 0.92612073 |
| 68 | GATA2_20887958_ChIP-Seq_HPC-7_Mouse | 0.92340116 |
| 69 | EZH2_22144423_ChIP-Seq_EOC_Human | 0.92161827 |
| 70 | SMRT_27268052_Chip-Seq_Bcells_Human | 0.91572620 |
| 71 | ETV2_25802403_ChIP-Seq_MESCs_Mouse | 0.91412668 |
| 72 | TP63_23658742_ChIP-Seq_EP156T_Human | 0.90958602 |
| 73 | ERA_27197147_Chip-Seq_ENDOMETRIOID-ADENOCARCINOMA_Human | 0.90625070 |
| 74 | SMAD_19615063_ChIP-ChIP_OVARY_Human | 0.90487343 |
| 75 | NCOR_22424771_ChIP-Seq_293T_Human | 0.89227437 |
| 76 | FOXP3_17237761_ChIP-ChIP_TREG_Mouse | 0.87493937 |
| 77 | STAT4_19710469_ChIP-ChIP_TH1__Mouse | 0.87063721 |
| 78 | STAT1_20625510_ChIP-Seq_HELA_Human | 0.86807980 |
| 79 | VDR_24787735_ChIP-Seq_THP-1_Human | 0.86289900 |
| 80 | HIF1A_21447827_ChIP-Seq_MCF-7_Human | 0.86178292 |
| 81 | IRF1_19129219_ChIP-ChIP_H3396_Human | 0.85946818 |
| 82 | SMRT_22465074_ChIP-Seq_MACROPHAGES_Mouse | 0.85816144 |
| 83 | TCFCP2L1_18555785_Chip-Seq_ESCs_Mouse | 0.84237727 |
| 84 | CEBPB_22108803_ChIP-Seq_LS180_Human | 0.83128053 |
| 85 | NMYC_18555785_Chip-Seq_ESCs_Mouse | 0.82720563 |
| 86 | MECOM_23826213_ChIP-Seq_KASUMI_Mouse | 0.81825006 |
| 87 | ETS2_20176728_ChIP-ChIP_TROPHOBLAST_STEM_CELLS_Mouse | 0.81662048 |
| 88 | ZNF652_21678463_ChIP-ChIP_ZR75-1_Human | 0.81043988 |
| 89 | PPARG_20176806_ChIP-Seq_MACROPHAGES_Mouse | 0.80981499 |
| 90 | MYC_19829295_ChIP-Seq_ESCs_Human | 0.80170540 |
| 91 | AR_25329375_ChIP-Seq_VCAP_Human | 0.79845002 |
| 92 | TAL1_26923725_Chip-Seq_HPCs_Mouse | 0.79106581 |
| 93 | RXR_22108803_ChIP-Seq_LS180_Human | 0.78808858 |
| 94 | AR_22383394_ChIP-Seq_PROSTATE_CANCER_Human | 0.76880884 |
| 95 | STAT1_17558387_ChIP-Seq_HELA_Human | 0.76045865 |
| 96 | LMO2_20887958_ChIP-Seq_HPC-7_Mouse | 0.75992530 |
| 97 | JARID2_20075857_ChIP-Seq_MESCs_Mouse | 0.75211342 |
| 98 | NFYA_21822215_ChIP-Seq_K562_Human | 0.75126711 |
| 99 | WDR5_24793694_ChIP-Seq_LNCAP_Human | 0.74997932 |
| 100 | POU5F1_16518401_ChIP-PET_MESCs_Mouse | 0.74725765 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | MP0003252_abnormal_bile_duct | 6.20561226 |
| 2 | MP0000569_abnormal_digit_pigmentation | 5.41812572 |
| 3 | MP0003011_delayed_dark_adaptation | 5.13565837 |
| 4 | MP0006082_CNS_inflammation | 3.67403949 |
| 5 | MP0002736_abnormal_nociception_after | 3.49910429 |
| 6 | MP0001986_abnormal_taste_sensitivity | 2.97924637 |
| 7 | MP0000371_diluted_coat_color | 2.81947224 |
| 8 | MP0001835_abnormal_antigen_presentation | 2.58526510 |
| 9 | MP0009785_altered_susceptibility_to | 2.54791670 |
| 10 | MP0002148_abnormal_hypersensitivity_rea | 2.41850386 |
| 11 | MP0003303_peritoneal_inflammation | 2.41135434 |
| 12 | MP0001968_abnormal_touch/_nociception | 2.40253238 |
| 13 | MP0003186_abnormal_redox_activity | 2.32063135 |
| 14 | MP0003724_increased_susceptibility_to | 2.18886927 |
| 15 | MP0005025_abnormal_response_to | 2.18111586 |
| 16 | MP0003195_calcinosis | 2.04203170 |
| 17 | MP0002138_abnormal_hepatobiliary_system | 1.99002259 |
| 18 | MP0005387_immune_system_phenotype | 1.92866280 |
| 19 | MP0001790_abnormal_immune_system | 1.92866280 |
| 20 | MP0004510_myositis | 1.89779200 |
| 21 | MP0005671_abnormal_response_to | 1.82320027 |
| 22 | MP0000685_abnormal_immune_system | 1.79339486 |
| 23 | MP0009764_decreased_sensitivity_to | 1.76878785 |
| 24 | MP0001501_abnormal_sleep_pattern | 1.74970316 |
| 25 | MP0002139_abnormal_hepatobiliary_system | 1.74458550 |
| 26 | MP0005000_abnormal_immune_tolerance | 1.67571877 |
| 27 | MP0003172_abnormal_lysosome_physiology | 1.67406248 |
| 28 | MP0005334_abnormal_fat_pad | 1.65445159 |
| 29 | MP0003646_muscle_fatigue | 1.62841664 |
| 30 | MP0001800_abnormal_humoral_immune | 1.61266747 |
| 31 | MP0005647_abnormal_sex_gland | 1.52163189 |
| 32 | MP0001348_abnormal_lacrimal_gland | 1.51577267 |
| 33 | MP0002723_abnormal_immune_serum | 1.48886878 |
| 34 | MP0004130_abnormal_muscle_cell | 1.47950486 |
| 35 | MP0005253_abnormal_eye_physiology | 1.43132304 |
| 36 | MP0009840_abnormal_foam_cell | 1.43111343 |
| 37 | MP0002419_abnormal_innate_immunity | 1.37302286 |
| 38 | MP0003436_decreased_susceptibility_to | 1.36489184 |
| 39 | MP0004947_skin_inflammation | 1.36215104 |
| 40 | MP0002452_abnormal_antigen_presenting | 1.35064177 |
| 41 | MP0009745_abnormal_behavioral_response | 1.33912825 |
| 42 | MP0005174_abnormal_tail_pigmentation | 1.33316483 |
| 43 | MP0002837_dystrophic_cardiac_calcinosis | 1.31616718 |
| 44 | MP0001666_abnormal_nutrient_absorption | 1.26526509 |
| 45 | MP0001845_abnormal_inflammatory_respons | 1.25638800 |
| 46 | MP0010155_abnormal_intestine_physiology | 1.23808044 |
| 47 | MP0005310_abnormal_salivary_gland | 1.23666259 |
| 48 | MP0002693_abnormal_pancreas_physiology | 1.17556177 |
| 49 | MP0003950_abnormal_plasma_membrane | 1.15248235 |
| 50 | MP0004381_abnormal_hair_follicle | 1.14647941 |
| 51 | MP0001819_abnormal_immune_cell | 1.14451244 |
| 52 | MP0002420_abnormal_adaptive_immunity | 1.12382492 |
| 53 | MP0009046_muscle_twitch | 1.12156472 |
| 54 | MP0002163_abnormal_gland_morphology | 1.08110969 |
| 55 | MP0000343_altered_response_to | 1.05820542 |
| 56 | MP0005083_abnormal_biliary_tract | 1.05665911 |
| 57 | MP0009763_increased_sensitivity_to | 1.05603560 |
| 58 | MP0004264_abnormal_extraembryonic_tissu | 1.03325928 |
| 59 | MP0008469_abnormal_protein_level | 1.02733709 |
| 60 | MP0005166_decreased_susceptibility_to | 1.00431651 |
| 61 | MP0005075_abnormal_melanosome_morpholog | 0.99937162 |
| 62 | MP0002075_abnormal_coat/hair_pigmentati | 0.99142892 |
| 63 | MP0004742_abnormal_vestibular_system | 0.97181223 |
| 64 | MP0005636_abnormal_mineral_homeostasis | 0.95123379 |
| 65 | MP0005410_abnormal_fertilization | 0.93345370 |
| 66 | MP0003806_abnormal_nucleotide_metabolis | 0.92986466 |
| 67 | MP0005645_abnormal_hypothalamus_physiol | 0.92492906 |
| 68 | MP0002118_abnormal_lipid_homeostasis | 0.90416031 |
| 69 | MP0001533_abnormal_skeleton_physiology | 0.90204940 |
| 70 | MP0002877_abnormal_melanocyte_morpholog | 0.88218155 |
| 71 | MP0006072_abnormal_retinal_apoptosis | 0.84597643 |
| 72 | MP0000015_abnormal_ear_pigmentation | 0.84210545 |
| 73 | MP0005085_abnormal_gallbladder_physiolo | 0.83768268 |
| 74 | MP0003075_altered_response_to | 0.81639659 |
| 75 | MP0005670_abnormal_white_adipose | 0.78114100 |
| 76 | MP0003137_abnormal_impulse_conducting | 0.77897796 |
| 77 | MP0009765_abnormal_xenobiotic_induced | 0.76897520 |
| 78 | MP0008961_abnormal_basal_metabolism | 0.75480236 |
| 79 | MP0008004_abnormal_stomach_pH | 0.73346698 |
| 80 | MP0003690_abnormal_glial_cell | 0.72312378 |
| 81 | MP0000609_abnormal_liver_physiology | 0.71592169 |
| 82 | MP0000427_abnormal_hair_cycle | 0.69751966 |
| 83 | MP0009333_abnormal_splenocyte_physiolog | 0.69174356 |
| 84 | MP0003448_altered_tumor_morphology | 0.68954116 |
| 85 | MP0003718_maternal_effect | 0.67099971 |
| 86 | MP0002405_respiratory_system_inflammati | 0.66307114 |
| 87 | MP0002064_seizures | 0.66230385 |
| 88 | MP0001873_stomach_inflammation | 0.65932174 |
| 89 | MP0000372_irregular_coat_pigmentation | 0.65151958 |
| 90 | MP0002733_abnormal_thermal_nociception | 0.64758781 |
| 91 | MP0001764_abnormal_homeostasis | 0.64510270 |
| 92 | MP0001186_pigmentation_phenotype | 0.64198810 |
| 93 | MP0005646_abnormal_pituitary_gland | 0.63716320 |
| 94 | MP0006035_abnormal_mitochondrial_morpho | 0.63608567 |
| 95 | MP0005084_abnormal_gallbladder_morpholo | 0.62556359 |
| 96 | MP0009384_cardiac_valve_regurgitation | 0.62065504 |
| 97 | MP0003763_abnormal_thymus_physiology | 0.60891437 |
| 98 | MP0000716_abnormal_immune_system | 0.60343120 |
| 99 | MP0000013_abnormal_adipose_tissue | 0.60316891 |
| 100 | MP0005464_abnormal_platelet_physiology | 0.59648324 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | Action tremor (HP:0002345) | 9.62782050 |
| 2 | Progressive cerebellar ataxia (HP:0002073) | 7.71786309 |
| 3 | Prostate neoplasm (HP:0100787) | 7.56775772 |
| 4 | Slow saccadic eye movements (HP:0000514) | 6.47984108 |
| 5 | Absence seizures (HP:0002121) | 6.42325456 |
| 6 | Abnormality of the hepatic vasculature (HP:0006707) | 5.40003610 |
| 7 | Urinary bladder sphincter dysfunction (HP:0002839) | 5.16178290 |
| 8 | Pendular nystagmus (HP:0012043) | 5.15389868 |
| 9 | Postural instability (HP:0002172) | 4.98511228 |
| 10 | Postural tremor (HP:0002174) | 4.88852737 |
| 11 | Gaze-evoked nystagmus (HP:0000640) | 4.87812335 |
| 12 | Dialeptic seizures (HP:0011146) | 4.79867293 |
| 13 | Dysdiadochokinesis (HP:0002075) | 4.77380237 |
| 14 | Severe visual impairment (HP:0001141) | 4.54461726 |
| 15 | Limb ataxia (HP:0002070) | 4.26343325 |
| 16 | Hypochromic microcytic anemia (HP:0004840) | 4.17225155 |
| 17 | Abnormality of the prostate (HP:0008775) | 4.11518735 |
| 18 | Impaired smooth pursuit (HP:0007772) | 4.03644151 |
| 19 | Impaired vibratory sensation (HP:0002495) | 3.97405364 |
| 20 | Abnormality of macular pigmentation (HP:0008002) | 3.46375525 |
| 21 | Focal seizures (HP:0007359) | 3.35098730 |
| 22 | Impaired proprioception (HP:0010831) | 3.27874542 |
| 23 | Gingival bleeding (HP:0000225) | 3.15499687 |
| 24 | Hypochromic anemia (HP:0001931) | 2.71376101 |
| 25 | Abnormality of saccadic eye movements (HP:0000570) | 2.69559459 |
| 26 | Abnormality of ocular smooth pursuit (HP:0000617) | 2.68211242 |
| 27 | Loss of speech (HP:0002371) | 2.63581279 |
| 28 | Abnormality of male internal genitalia (HP:0000022) | 2.51681539 |
| 29 | Recurrent bacterial skin infections (HP:0005406) | 2.49583993 |
| 30 | Arterial thrombosis (HP:0004420) | 2.47907285 |
| 31 | Postnatal microcephaly (HP:0005484) | 2.46872042 |
| 32 | Areflexia of lower limbs (HP:0002522) | 2.42714439 |
| 33 | Focal motor seizures (HP:0011153) | 2.33142785 |
| 34 | Abnormality of vision evoked potentials (HP:0000649) | 2.32809160 |
| 35 | Recurrent abscess formation (HP:0002722) | 2.21870953 |
| 36 | Retrobulbar optic neuritis (HP:0100654) | 2.21244309 |
| 37 | Optic neuritis (HP:0100653) | 2.21244309 |
| 38 | Bilateral microphthalmos (HP:0007633) | 2.10458025 |
| 39 | Chorioretinal atrophy (HP:0000533) | 2.08643976 |
| 40 | Amaurosis fugax (HP:0100576) | 2.06514157 |
| 41 | Tinnitus (HP:0000360) | 2.06225748 |
| 42 | Genetic anticipation (HP:0003743) | 10.6587631 |
| 43 | Dysmetric saccades (HP:0000641) | 10.3643472 |
| 44 | Abnormality of T cell number (HP:0011839) | 1.98635766 |
| 45 | Chest pain (HP:0100749) | 1.98290811 |
| 46 | Clumsiness (HP:0002312) | 1.97709091 |
| 47 | Fair hair (HP:0002286) | 1.92876697 |
| 48 | Rib fusion (HP:0000902) | 1.92795938 |
| 49 | Anorexia (HP:0002039) | 1.92674329 |
| 50 | Vitreoretinal degeneration (HP:0000655) | 1.92153988 |
| 51 | Anomalous pulmonary venous return (HP:0010772) | 1.91032958 |
| 52 | Orchitis (HP:0100796) | 1.88918537 |
| 53 | Bradykinesia (HP:0002067) | 1.87210835 |
| 54 | Pruritus (HP:0000989) | 1.82293780 |
| 55 | Increased corneal curvature (HP:0100692) | 1.82119852 |
| 56 | Keratoconus (HP:0000563) | 1.82119852 |
| 57 | T lymphocytopenia (HP:0005403) | 1.81958641 |
| 58 | Inflammation of the large intestine (HP:0002037) | 1.81353411 |
| 59 | Fasciculations (HP:0002380) | 1.79843342 |
| 60 | Oculomotor apraxia (HP:0000657) | 1.79782133 |
| 61 | Autoimmune thrombocytopenia (HP:0001973) | 1.78007253 |
| 62 | Dysostosis multiplex (HP:0000943) | 1.77130821 |
| 63 | Dynein arm defect of respiratory motile cilia (HP:0012255) | 1.77082103 |
| 64 | Absent/shortened dynein arms (HP:0200106) | 1.77082103 |
| 65 | Portal hypertension (HP:0001409) | 1.76341026 |
| 66 | Chronic obstructive pulmonary disease (HP:0006510) | 1.73997371 |
| 67 | Obstructive lung disease (HP:0006536) | 1.73997371 |
| 68 | Retinitis pigmentosa (HP:0000510) | 1.73510349 |
| 69 | Biliary tract neoplasm (HP:0100574) | 1.73104723 |
| 70 | Atonic seizures (HP:0010819) | 1.73095872 |
| 71 | Hyperthyroidism (HP:0000836) | 1.72234927 |
| 72 | Macular degeneration (HP:0000608) | 1.71082647 |
| 73 | Vertigo (HP:0002321) | 1.70499766 |
| 74 | Microcytic anemia (HP:0001935) | 1.70005892 |
| 75 | Abnormal respiratory motile cilium physiology (HP:0012261) | 1.69665606 |
| 76 | Abnormality of the pulmonary veins (HP:0011718) | 1.69405284 |
| 77 | Myoclonus (HP:0001336) | 1.66950048 |
| 78 | Aplasia/Hypoplasia of the macula (HP:0008059) | 1.66831974 |
| 79 | Urinary glycosaminoglycan excretion (HP:0003541) | 1.65368899 |
| 80 | Mucopolysacchariduria (HP:0008155) | 1.65368899 |
| 81 | Hemiplegia (HP:0002301) | 1.64089075 |
| 82 | Gastrointestinal inflammation (HP:0004386) | 1.61995141 |
| 83 | Dysmetria (HP:0001310) | 1.61876675 |
| 84 | Decreased electroretinogram (ERG) amplitude (HP:0000654) | 1.61627097 |
| 85 | Abnormality of polysaccharide metabolism (HP:0011012) | 1.60257765 |
| 86 | Abnormality of glycosaminoglycan metabolism (HP:0004371) | 1.60257765 |
| 87 | Abnormality of mucopolysaccharide metabolism (HP:0011020) | 1.60257765 |
| 88 | Severe Myopia (HP:0011003) | 1.59597319 |
| 89 | Myositis (HP:0100614) | 1.59168926 |
| 90 | Generalized hypopigmentation of hair (HP:0011358) | 1.58374695 |
| 91 | Hyperventilation (HP:0002883) | 1.56341133 |
| 92 | Increased IgM level (HP:0003496) | 1.56126064 |
| 93 | Aplasia/Hypoplasia of the fovea (HP:0008060) | 1.56031980 |
| 94 | Hypoplasia of the fovea (HP:0007750) | 1.56031980 |
| 95 | Aplasia/Hypoplasia affecting the retina (HP:0008061) | 1.53119204 |
| 96 | Hypoproteinemia (HP:0003075) | 1.52883817 |
| 97 | Fused cervical vertebrae (HP:0002949) | 1.50797615 |
| 98 | Increased density of long bones (HP:0006392) | 1.50648589 |
| 99 | Abnormal delayed hypersensitivity skin test (HP:0002963) | 1.50628566 |
| 100 | Respiratory insufficiency due to defective ciliary clearance (HP:0200073) | 1.50353358 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | OXSR1 | 5.67812916 |
| 2 | FRK | 4.26405122 |
| 3 | TXK | 2.45388164 |
| 4 | WNK4 | 2.43367565 |
| 5 | ADRBK2 | 2.32389665 |
| 6 | TNK2 | 2.22655517 |
| 7 | MAP3K7 | 2.10943582 |
| 8 | CDK19 | 10.8314644 |
| 9 | GRK1 | 1.96052490 |
| 10 | IKBKE | 1.82046576 |
| 11 | ZAK | 1.78953232 |
| 12 | GRK7 | 1.77802353 |
| 13 | ACVR1B | 1.64966302 |
| 14 | STK39 | 1.64726710 |
| 15 | ALK | 1.59232248 |
| 16 | TYK2 | 1.58812268 |
| 17 | BMPR2 | 1.47687900 |
| 18 | RPS6KB2 | 1.43537016 |
| 19 | JAK1 | 1.36765989 |
| 20 | JAK3 | 1.33869017 |
| 21 | BRSK1 | 1.17004361 |
| 22 | JAK2 | 1.08948240 |
| 23 | TLK1 | 1.04673587 |
| 24 | MELK | 1.02245685 |
| 25 | KIT | 0.98324107 |
| 26 | IKBKB | 0.96055245 |
| 27 | MAPK11 | 0.94625200 |
| 28 | IRAK3 | 0.92139905 |
| 29 | STK3 | 0.91686105 |
| 30 | BMPR1B | 0.91601536 |
| 31 | RIPK4 | 0.87893385 |
| 32 | TBK1 | 0.85834234 |
| 33 | MAP4K1 | 0.83224945 |
| 34 | MATK | 0.80457252 |
| 35 | TAOK3 | 0.79596536 |
| 36 | BLK | 0.76361418 |
| 37 | PINK1 | 0.76206446 |
| 38 | PDPK1 | 0.70670237 |
| 39 | BCR | 0.68206710 |
| 40 | WNK1 | 0.67124019 |
| 41 | IRAK4 | 0.65282872 |
| 42 | STK11 | 0.64987625 |
| 43 | PDK1 | 0.64406364 |
| 44 | BTK | 0.63723904 |
| 45 | CHUK | 0.63414733 |
| 46 | MAP3K14 | 0.62933940 |
| 47 | FGFR4 | 0.62410789 |
| 48 | STK38 | 0.62303043 |
| 49 | FER | 0.61915833 |
| 50 | MKNK1 | 0.56261324 |
| 51 | CSK | 0.55950590 |
| 52 | CDK4 | 0.55536331 |
| 53 | PKN1 | 0.55277110 |
| 54 | RPS6KA5 | 0.54397820 |
| 55 | RIPK1 | 0.52889937 |
| 56 | MKNK2 | 0.50185719 |
| 57 | HIPK2 | 0.46485396 |
| 58 | TGFBR1 | 0.46151021 |
| 59 | MAP3K5 | 0.46084916 |
| 60 | PIM1 | 0.45196025 |
| 61 | CDC42BPA | 0.43138951 |
| 62 | ITK | 0.42007510 |
| 63 | TAOK2 | 0.38722780 |
| 64 | FGFR3 | 0.38408840 |
| 65 | ABL2 | 0.37033082 |
| 66 | MST1R | 0.36884833 |
| 67 | MTOR | 0.36772965 |
| 68 | MAPKAPK5 | 0.36415589 |
| 69 | CHEK2 | 0.36182928 |
| 70 | STK10 | 0.34387729 |
| 71 | CHEK1 | 0.33146523 |
| 72 | MAP2K6 | 0.31944527 |
| 73 | ADRBK1 | 0.31049511 |
| 74 | LYN | 0.29745187 |
| 75 | PRKCQ | 0.27473917 |
| 76 | LCK | 0.26200166 |
| 77 | PRKAA2 | 0.25594727 |
| 78 | NME2 | 0.24943170 |
| 79 | CDK11A | 0.24677021 |
| 80 | AURKA | 0.24671113 |
| 81 | CAMKK2 | 0.23905654 |
| 82 | MAPK7 | 0.23568451 |
| 83 | ABL1 | 0.23256748 |
| 84 | CDK15 | 0.22316916 |
| 85 | CSNK1A1 | 0.21910962 |
| 86 | PIM2 | 0.21300938 |
| 87 | CDK18 | 0.19699332 |
| 88 | PRPF4B | 0.19097131 |
| 89 | DAPK2 | 0.17863660 |
| 90 | ERBB2 | 0.16839816 |
| 91 | IGF1R | 0.16380614 |
| 92 | ZAP70 | 0.16138212 |
| 93 | KDR | 0.15034745 |
| 94 | GRK6 | 0.14453649 |
| 95 | PAK1 | 0.14417534 |
| 96 | VRK2 | 0.14394243 |
| 97 | DDR2 | 0.14367666 |
| 98 | RPS6KA4 | 0.12085321 |
| 99 | BMX | 0.11569175 |
| 100 | TESK2 | 0.11284786 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | Primary bile acid biosynthesis_Homo sapiens_hsa00120 | 7.35643529 |
| 2 | Cytosolic DNA-sensing pathway_Homo sapiens_hsa04623 | 3.52076413 |
| 3 | Allograft rejection_Homo sapiens_hsa05330 | 2.60250689 |
| 4 | Autoimmune thyroid disease_Homo sapiens_hsa05320 | 2.53165053 |
| 5 | Porphyrin and chlorophyll metabolism_Homo sapiens_hsa00860 | 2.45570165 |
| 6 | Graft-versus-host disease_Homo sapiens_hsa05332 | 2.41776824 |
| 7 | RIG-I-like receptor signaling pathway_Homo sapiens_hsa04622 | 2.37409768 |
| 8 | Glycosphingolipid biosynthesis - lacto and neolacto series_Homo sapiens_hsa00601 | 2.21264917 |
| 9 | Caffeine metabolism_Homo sapiens_hsa00232 | 2.10751409 |
| 10 | Glycosphingolipid biosynthesis - globo series_Homo sapiens_hsa00603 | 2.04341777 |
| 11 | Influenza A_Homo sapiens_hsa05164 | 2.04120469 |
| 12 | Ascorbate and aldarate metabolism_Homo sapiens_hsa00053 | 1.97165442 |
| 13 | Toll-like receptor signaling pathway_Homo sapiens_hsa04620 | 1.95592125 |
| 14 | Hepatitis C_Homo sapiens_hsa05160 | 1.95457464 |
| 15 | Steroid hormone biosynthesis_Homo sapiens_hsa00140 | 1.88880500 |
| 16 | Herpes simplex infection_Homo sapiens_hsa05168 | 1.87688849 |
| 17 | Retinol metabolism_Homo sapiens_hsa00830 | 1.77028667 |
| 18 | Type I diabetes mellitus_Homo sapiens_hsa04940 | 1.67216418 |
| 19 | Fatty acid biosynthesis_Homo sapiens_hsa00061 | 1.62489122 |
| 20 | Measles_Homo sapiens_hsa05162 | 1.59126610 |
| 21 | Drug metabolism - other enzymes_Homo sapiens_hsa00983 | 1.57618649 |
| 22 | Asthma_Homo sapiens_hsa05310 | 1.53804375 |
| 23 | Tryptophan metabolism_Homo sapiens_hsa00380 | 1.51860747 |
| 24 | Intestinal immune network for IgA production_Homo sapiens_hsa04672 | 1.49616775 |
| 25 | Inflammatory bowel disease (IBD)_Homo sapiens_hsa05321 | 1.41540541 |
| 26 | NF-kappa B signaling pathway_Homo sapiens_hsa04064 | 1.41528096 |
| 27 | African trypanosomiasis_Homo sapiens_hsa05143 | 1.35090104 |
| 28 | Glycosaminoglycan degradation_Homo sapiens_hsa00531 | 1.34055361 |
| 29 | TNF signaling pathway_Homo sapiens_hsa04668 | 1.21049294 |
| 30 | NOD-like receptor signaling pathway_Homo sapiens_hsa04621 | 1.18468947 |
| 31 | Rheumatoid arthritis_Homo sapiens_hsa05323 | 1.16748073 |
| 32 | Glycosylphosphatidylinositol(GPI)-anchor biosynthesis_Homo sapiens_hsa00563 | 1.10493540 |
| 33 | Butanoate metabolism_Homo sapiens_hsa00650 | 1.08622841 |
| 34 | Natural killer cell mediated cytotoxicity_Homo sapiens_hsa04650 | 1.06676689 |
| 35 | Pentose and glucuronate interconversions_Homo sapiens_hsa00040 | 1.05927599 |
| 36 | Drug metabolism - cytochrome P450_Homo sapiens_hsa00982 | 1.04431862 |
| 37 | Staphylococcus aureus infection_Homo sapiens_hsa05150 | 1.01801167 |
| 38 | Ether lipid metabolism_Homo sapiens_hsa00565 | 1.01492699 |
| 39 | Neuroactive ligand-receptor interaction_Homo sapiens_hsa04080 | 1.00298144 |
| 40 | Leishmaniasis_Homo sapiens_hsa05140 | 1.00047089 |
| 41 | Olfactory transduction_Homo sapiens_hsa04740 | 0.99629440 |
| 42 | * Cytokine-cytokine receptor interaction_Homo sapiens_hsa04060 | 0.98150511 |
| 43 | Osteoclast differentiation_Homo sapiens_hsa04380 | 0.92123548 |
| 44 | Malaria_Homo sapiens_hsa05144 | 0.90906936 |
| 45 | * Jak-STAT signaling pathway_Homo sapiens_hsa04630 | 0.90084275 |
| 46 | Primary immunodeficiency_Homo sapiens_hsa05340 | 0.89804901 |
| 47 | Chagas disease (American trypanosomiasis)_Homo sapiens_hsa05142 | 0.89161146 |
| 48 | Hematopoietic cell lineage_Homo sapiens_hsa04640 | 0.81996306 |
| 49 | Pertussis_Homo sapiens_hsa05133 | 0.79513394 |
| 50 | Lysosome_Homo sapiens_hsa04142 | 0.75952307 |
| 51 | Viral myocarditis_Homo sapiens_hsa05416 | 0.75593624 |
| 52 | Antigen processing and presentation_Homo sapiens_hsa04612 | 0.72312039 |
| 53 | T cell receptor signaling pathway_Homo sapiens_hsa04660 | 0.72048603 |
| 54 | Epithelial cell signaling in Helicobacter pylori infection_Homo sapiens_hsa05120 | 0.70892296 |
| 55 | Starch and sucrose metabolism_Homo sapiens_hsa00500 | 0.68960740 |
| 56 | PPAR signaling pathway_Homo sapiens_hsa03320 | 0.67603523 |
| 57 | Adipocytokine signaling pathway_Homo sapiens_hsa04920 | 0.65647683 |
| 58 | Tuberculosis_Homo sapiens_hsa05152 | 0.63151621 |
| 59 | Chemical carcinogenesis_Homo sapiens_hsa05204 | 0.62996903 |
| 60 | Fc gamma R-mediated phagocytosis_Homo sapiens_hsa04666 | 0.62280224 |
| 61 | Linoleic acid metabolism_Homo sapiens_hsa00591 | 0.61715441 |
| 62 | Other glycan degradation_Homo sapiens_hsa00511 | 0.61223915 |
| 63 | Legionellosis_Homo sapiens_hsa05134 | 0.60210660 |
| 64 | Toxoplasmosis_Homo sapiens_hsa05145 | 0.60128891 |
| 65 | Glycosaminoglycan biosynthesis - chondroitin sulfate / dermatan sulfate_Homo sapiens_hsa00532 | 0.59531976 |
| 66 | Renin-angiotensin system_Homo sapiens_hsa04614 | 0.56832721 |
| 67 | RNA polymerase_Homo sapiens_hsa03020 | 0.56607543 |
| 68 | Chemokine signaling pathway_Homo sapiens_hsa04062 | 0.56064535 |
| 69 | Metabolism of xenobiotics by cytochrome P450_Homo sapiens_hsa00980 | 0.54469238 |
| 70 | ABC transporters_Homo sapiens_hsa02010 | 0.50596189 |
| 71 | Cyanoamino acid metabolism_Homo sapiens_hsa00460 | 0.49468537 |
| 72 | Salmonella infection_Homo sapiens_hsa05132 | 0.47001260 |
| 73 | Cysteine and methionine metabolism_Homo sapiens_hsa00270 | 0.43367681 |
| 74 | Synthesis and degradation of ketone bodies_Homo sapiens_hsa00072 | 0.42674685 |
| 75 | Cell adhesion molecules (CAMs)_Homo sapiens_hsa04514 | 0.42407951 |
| 76 | Taurine and hypotaurine metabolism_Homo sapiens_hsa00430 | 0.40660610 |
| 77 | Mucin type O-Glycan biosynthesis_Homo sapiens_hsa00512 | 0.35359814 |
| 78 | B cell receptor signaling pathway_Homo sapiens_hsa04662 | 0.32116119 |
| 79 | alpha-Linolenic acid metabolism_Homo sapiens_hsa00592 | 0.31019040 |
| 80 | Sphingolipid metabolism_Homo sapiens_hsa00600 | 0.29420727 |
| 81 | Insulin resistance_Homo sapiens_hsa04931 | 0.29236482 |
| 82 | Hepatitis B_Homo sapiens_hsa05161 | 0.29000949 |
| 83 | Glycosaminoglycan biosynthesis - keratan sulfate_Homo sapiens_hsa00533 | 0.27705081 |
| 84 | Apoptosis_Homo sapiens_hsa04210 | 0.25825955 |
| 85 | Inflammatory mediator regulation of TRP channels_Homo sapiens_hsa04750 | 0.25495503 |
| 86 | Rap1 signaling pathway_Homo sapiens_hsa04015 | 0.25100841 |
| 87 | Type II diabetes mellitus_Homo sapiens_hsa04930 | 0.23558044 |
| 88 | Glycosphingolipid biosynthesis - ganglio series_Homo sapiens_hsa00604 | 0.22623573 |
| 89 | MAPK signaling pathway_Homo sapiens_hsa04010 | 0.21995418 |
| 90 | Complement and coagulation cascades_Homo sapiens_hsa04610 | 0.20550092 |
| 91 | Epstein-Barr virus infection_Homo sapiens_hsa05169 | 0.20414158 |
| 92 | Regulation of actin cytoskeleton_Homo sapiens_hsa04810 | 0.19164985 |
| 93 | Amyotrophic lateral sclerosis (ALS)_Homo sapiens_hsa05014 | 0.17856438 |
| 94 | Renal cell carcinoma_Homo sapiens_hsa05211 | 0.16748002 |
| 95 | N-Glycan biosynthesis_Homo sapiens_hsa00510 | 0.16054802 |
| 96 | HTLV-I infection_Homo sapiens_hsa05166 | 0.14274426 |
| 97 | Sphingolipid signaling pathway_Homo sapiens_hsa04071 | 0.14059221 |
| 98 | Prolactin signaling pathway_Homo sapiens_hsa04917 | 0.13126385 |
| 99 | Arachidonic acid metabolism_Homo sapiens_hsa00590 | 0.12957468 |
| 100 | Regulation of lipolysis in adipocytes_Homo sapiens_hsa04923 | 0.12509815 |

